Atlas Trials

Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma

Clinical trial NCT01762150 · COMPLETED

Trial details

NCT number
NCT01762150
Sponsor
Peking University Cancer Hospital & Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2011-06-01
Primary completion
2016-12-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.